Parkinsonism Following Chimeric Antigen Receptor T Cell Therapy
Gudera J, Baehring J, Karschnia P. Parkinsonism Following Chimeric Antigen Receptor T Cell Therapy. JAMA Neurology 2024, 81 PMID: 39133506, DOI: 10.1001/jamaneurol.2024.2506.Peer-Reviewed Original ResearchNeurological complications of medical therapies in haematological malignancies
Baehring J, Soussain C. Neurological complications of medical therapies in haematological malignancies. 2024, 109-122. DOI: 10.1093/med/9780198884903.003.0008.Peer-Reviewed Original ResearchChimeric antigen receptorStem cell transplantationHaematological malignanciesCell transplantationMedical therapyNeurological complicationsAssociated with posterior reversible encephalopathy syndromeAllogeneic stem cell transplantationGraft-versus-host diseasePosterior reversible encephalopathy syndromeRisk of opportunistic infectionsCerebrospinal fluidHaematopoietic stem cell transplantationCentral nervous system involvementComplications of medical therapySpectrum of neurological complicationsT-cell therapyGraft-versus-hostTumor lysis syndromeReversible encephalopathy syndromeDural sinus thrombosisNervous system involvementBispecific monoclonal antibodyAdaptive immune systemSpecific to patients